Use of antimalarial drugs in Zimbabwe

dc.contributor.author	Ball, D.
dc.contributor.author	Jeffery, M.
dc.date.accessioned	2016-10-14T12:30:26Z
dc.date.available	2016-10-14T12:30:26Z
dc.date.issued	2001
dc.identifier.citation	Ball, D. & Jeffrey, M. (2001). Use of antimalarial drugs in Zimbabwe. Central African Journal of Medicine, 47 (6), 164-165.	en_US
dc.identifier.issn	0089176
dc.identifier.uri	http://hdl.handle.net/10646/2838
dc.description.abstract	Malaria is a world-wide problem which is estimated to contribute to 2.3% of global disease' and is an increasing problem, particularly in developing countries.2 In Zimbabwe, the development of widespread resistance to antimalarial drugs has been prevented through a comprehensive national malaria strategy including the development and enforcement of national guidelines tor the prophylaxis and treatment of malaria. However, in recent years numerous anecdotal accounts have circulated in the private sector of failure of malaria chemoprophylax is and treatment. This study set out to explore the use of antimalarial drug-products amongst doctors and pharmacists so as to identify potential problems requiring further investigation.	en_US
dc.language.iso	en_ZW	en_US
dc.publisher	University of Zimbabwe, College of Health Sciences	en_US
dc.subject	Malaria	en_US
dc.subject	Drugs	en_US
dc.subject	antimalarial drugs	en_US
dc.title	Use of antimalarial drugs in Zimbabwe	en_US
dc.type	Article	en_US